FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!
On Tuesday, September 29, 2020 at 1pm (ET), CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: FDA Drug Topics: An Overview of Naloxone and FDA’s Efforts to Expand Access. This webinar was designed to aid healthcare professionals in understanding the forms of naloxone that are available for the emergency treatment of acute opioid overdose and also increased knowledge of steps that FDA has taken to expand community access to naloxone.
View Presentation Here: https://collaboration.fda.gov/pc6brzrt3d02/
Download Presentation Slides: An Overview of Naloxone and FDA’s Efforts to Expand Access (PDF - 1.32MB)
Activity Outline and Continuing Education Information: An Overview of Naloxone and FDA’s Efforts to Expand Access (PDF - 170KB)
If you have never attended an Adobe Connect meeting before:
Test your connection: Adobe Connect Diagnostic Test
Get a quick overview: Discover Adobe Connect Solutions
Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.
Resources For You